Literature DB >> 30972736

Giant basal cell carcinoma: clinical-histological characteristics of 115 cases.

Martha R Vaca-Aguilera1, Elizabeth Guevara-Gutiérrez1, Juan G Barrientos-García1, Alberto Tlacuilo-Parra2.   

Abstract

INTRODUCTION: Giant basal cell carcinoma (GBCC) is a tumor ≥5 cm in size, with aggressive biological behavior, that represents 1% of basal cell carcinomas (BCC), and studies regarding it are scarce. Our objective was to investigate the clinical-histopathological characteristics of GBCC and the risk factors associated with its development.
METHODS: A retrospective study over 8 years included patients with the clinical and histopathological diagnosis of GBCC. Age, sex, localization, size, evolution time, risk factors, and histological variants were compared to conventional BCC. Descriptive and inferential statistics were used, and a value of P < 0.05 was considered statistically significant.
RESULTS: Of 5958 patients with BCC, 115 (2%) of them corresponded to GBCC. The average patient age was 73 ± 11 years, and the male sex (52%) and localization on the head and neck (63%) predominated. Average tumor size was 6.6 ± 2.2 cm, evolution time was 96 ± 86 months, and high-grade histological variants (51%) predominated. The group with GBCC had higher age (P < 0.01), greater frequency in the male sex (P = 0.01), longer evolution time (P < 0.01); a greater prevalence of risk factors (24% vs. 16%, P = 0.01), antecedents of other types of cancer (P = 0.03), and of burns (P = 0.03); and a greater frequency of high-grade histological variants (51% vs. 29%, P < 0.01).
CONCLUSIONS: This is the largest series of GBCC published to date. Findings are similar to those previously reported, although the prevalence found here was greater.
© 2019 The International Society of Dermatology.

Entities:  

Mesh:

Year:  2019        PMID: 30972736     DOI: 10.1111/ijd.14455

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  5 in total

1.  Epidemiological and clinicopathological analysis of basal cell carcinoma in Egyptian population: a 5-year retrospective multicenter study.

Authors:  Mohamed El-Khalawany; Hussein M M Hassab-El-Naby; Ahmed Mustafa Mousa; Ahmed Sameh; Mahmoud A Rageh; Rasha Mahmoud Genedy; Aya Magdy Hosny; Marwa A Aboelmagd; Soha Aboeldahab
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-23       Impact factor: 4.322

2.  Analysis of the occurrence and distribution of primary and recurrent basal cell carcinoma of head and neck coupled to the assessment of tumor microenvironment and Sonic hedgehog signaling.

Authors:  Jelena Moisejenko-Golubovica; Oleg Volkov; Anna Ivanova; Valerija Groma
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

3.  Slow-growing pedunculated nodule.

Authors:  Chaima Kouki; Nadine Kammoun; Khadija Sellami; Emna Bahloul; Manel Mallouli; Lobna Ayadi; Tahya Boudaouara; Hamida Turki
Journal:  Clin Case Rep       Date:  2022-02-18

4.  Management of patients with giant basal cell carcinoma during SARS COV2 outbreak in Italy.

Authors:  Cantisani Carmen; Rossi Raimondo; Nisticò Steven Paul; Vitiello Martina; Farnetani Francesca; Bennaro Luigi; Pellacani Giovanni
Journal:  Transl Biophotonics       Date:  2022-07-26

5.  A lobulated mass on the upper back with prominent vasculature: A giant basal cell carcinoma.

Authors:  Elysha M Kolitz; Brian L Scott; Travis Vandergriff; Melissa Mauskar
Journal:  Dermatol Reports       Date:  2021-04-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.